Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Baird

Showing results (51-60 of 366) with videos related to

Pageof 37
Sort By:
Bailliere'S Clinical Endocrinology and Metabolism|February 1, 1987
Clinical applications of LHRH analoguesH M Fraser, D T Baird
Journal of Reproduction and Fertility|January 1, 1976
The oestrous cycle of the ewe after active immunization against prostaglandin F-2 alphaR J Scaramuzzi, D T Baird
Clinical Endocrinology|February 1, 1987
Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogueC P West, D T Baird
Prostaglandins|June 1, 1986
The effect of intrauterine administration of prostacyclin on the contractility of the non-pregnant uterus in vivoM A Lumsden, D T Baird
BMJ (Clinical Research Ed.)|October 8, 1999
Science, medicine, and the future. ContraceptionD T Baird, A F Glasier
Oxford Reviews of Reproductive Biology|January 1, 1993
Inhibin and related peptides in the regulation of reproductionD T Baird, K B Smith
British Journal of Obstetrics and Gynaecology|November 1, 1984
The use of 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra-amniotic prostaglandin E2I T Cameron, D T Baird
The New England Journal of Medicine|May 27, 1993
Hormonal contraceptionD T Baird, A F Glasier
The Western Journal of Medicine|August 30, 2008
The science, medicine, and future of contraceptionD T Baird, A F Glasier
Contraception|July 1, 1992
A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancyK J Thong, D T Baird
Pageof 37

Showing results (51-60 of 366) with videos related to

Sort By:
Pageof 37
Bailliere'S Clinical Endocrinology and Metabolism|February 1, 1987
Clinical applications of LHRH analoguesH M Fraser, D T Baird
Journal of Reproduction and Fertility|January 1, 1976
The oestrous cycle of the ewe after active immunization against prostaglandin F-2 alphaR J Scaramuzzi, D T Baird
Clinical Endocrinology|February 1, 1987
Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogueC P West, D T Baird
Prostaglandins|June 1, 1986
The effect of intrauterine administration of prostacyclin on the contractility of the non-pregnant uterus in vivoM A Lumsden, D T Baird
BMJ (Clinical Research Ed.)|October 8, 1999
Science, medicine, and the future. ContraceptionD T Baird, A F Glasier
Oxford Reviews of Reproductive Biology|January 1, 1993
Inhibin and related peptides in the regulation of reproductionD T Baird, K B Smith
British Journal of Obstetrics and Gynaecology|November 1, 1984
The use of 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra-amniotic prostaglandin E2I T Cameron, D T Baird
The New England Journal of Medicine|May 27, 1993
Hormonal contraceptionD T Baird, A F Glasier
The Western Journal of Medicine|August 30, 2008
The science, medicine, and future of contraceptionD T Baird, A F Glasier
Contraception|July 1, 1992
A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancyK J Thong, D T Baird
Pageof 37